Recent Updates
Recently added Catalysts
INSP Positive Sentiment

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum

Key Takeaway: Inspire Medical Systems, Inc. will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026. The presentation is scheduled for 1:30 p.m. Eastern Time and will be available via live webcast. A replay will be accessible for two weeks on Inspire's Investor website. Inspire specializes in minimally invasive solutions for obstructive sleep apnea.
Price reaction · baseline $64.81 (2026-03-02 close) · hit pre-market · clean, no other INSP news in the window
day 0 close
+1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Inspire Medical Systems is presenting at a notable healthcare forum.
  • The presentation will be accessible via a live webcast.
  • Inspire's therapy is FDA approved, indicating regulatory confidence.
  • The company focuses on innovative solutions for obstructive sleep apnea.

Full Press Release Details

MINNEAPOLIS, March 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026.
Inspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation will be accessible via a live webcasthere.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website athttps://investors.inspiresleep.com.
About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visitwww.inspiresleep.com.

Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com617-549-2443

Frequently Asked Questions

When will Inspire Medical Systems present?

Inspire Medical Systems will present on March 17, 2026, at 1:30 p.m. ET.

How can I access the presentation?

The presentation will be accessible via a live webcast.

Where can I find the presentation replay?

A replay will be available for two weeks on Inspire's Investor website.

What does Inspire focus on?

Inspire focuses on innovative, minimally invasive solutions for obstructive sleep apnea.

Is Inspire's therapy FDA approved?

Yes, Inspire's therapy is FDA approved and also has EU MDR and PDMA approvals.

Last updated: Mar 3, 2026